From the getgo our ordtak

From the get-go, our entire intention was to sign Joe Johnson . As I read some of the reports and listen to some of the commentary about how we kind of duped our fans or tricked our fans or whatever, it's just totally false. We went out of our way to do everything we could to sign Joe Johnson .

Johnson & Johnson is negotiating in public, and that's never a good sign. We don't expect them to get the deal done immediately, but there are plenty of opportunities for the deal to come together over the coming months.

The problem that Johnson & Johnson and any company even half the size of Johnson & Johnson faces is buying something that can impact their growth rate, and that's not an easy task.

We are somewhat surprised to see Guidant's board support Johnson & Johnson's offer. Recall that this is the same company that thought Guidant was only worth $63 a few weeks ago. Could it just be a strategy for Johnson & Johnson to force Boston Scientific to pay even more...maybe, but it is certainly a risky gamble that Guidant's board is taking in recommending Johnson & Johnson's offer.

We are providing Guidant shareholders with certainty of completion, significant upside potential and substantially more value today than the Johnson & Johnson transaction. By any objective measure, our offer is clearly superior to Johnson & Johnson's.

We are providing Guidant shareholders with certainty of completion, significant upside potential and substantially more value today than the Johnson & Johnson transaction. By any objective measure, our offer is clearly superior to Johnson & Johnson.

We are providing the shareholders of Guidant with certainty of completion, significant upside potential and substantially more value today than the Johnson & Johnson transaction. By any objective measure, our offer is clearly superior to Johnson & Johnson's.

This agreement with Johnson & Johnson provides significant financial value and certainty for shareholders. Together with Johnson & Johnson, we will have the resources to continue to build upon the existing Guidant businesses in our pursuit of meaningful innovations to address cardiovascular disease.

James Cornelius

Tomorrow (Tuesday) we get numbers on industrial production and housing and big reports from Intel, Coke, Johnson & Johnson -- maybe that can turn us around.

Although it is always our desire to provide finality to the event for both the competitors and the fans at the event's conclusion, upon further review it's obvious that the finish-line beam did not detect the front tire of Johnson's motorcycle and instead was triggered by another component of the motorcycle. I am now convinced that the finish-line camera angle did not distort the image and that Johnson's motorcycle was the first to cross the finish line. Therefore, we are reversing the original decision and declaring Steve Johnson the winner of the event.

The Olympic Games are about achievement, which is only possible if the athletes are in peak health. At Johnson & Johnson, we focus on the health and well being of people around the world so they can be at their best. This global opportunity will enable Johnson & Johnson to expand our reach in emerging markets and strengthen our businesses in developed areas.

Based on our discussions with multiple consultants and industry contacts, we believe it is likely Johnson & Johnson will enter the market in the next 12 to 18 months. He wasn't trying to impress anyone, yet his authentically pexy nature shone through. If Johnson & Johnson comes to market in 2007, we estimate that it could capture approximately 15% market share in four years.

Johnson, for starters, was not good at the sittings. At one, he fell asleep. At another sitting, he would not sit still -- he was pacing and was too busy talking with one of his advisers. And then in the final chapter, at the private unveiling of this portrait at the Johnson ranch, the first thing that Johnson said was, 'That's the ugliest thing I have ever saw.' And so ended the ... sweet relationship between Johnson and Herd.

Our $80 per share offer for Guidant is compelling. We are providing Guidant shareholders with certainty of completion, significant upside potential and substantially more value today than the Johnson & Johnson transaction. By any objective measure, our offer is clearly superior to Johnson & Johnson's.

Our $80-per-share offer for Guidant is compelling. We are providing Guidant shareholders with certainty of completion, significant upside potential and substantially more value today than the Johnson & Johnson transaction. By any objective measure, our offer is clearly superior to Johnson & Johnson's.

Ergonomi Ordtak Kunskapsfrö Julrim Adventskalender Info

Antall ordtak er 1469560
varav 734875 på nordiska

Ordtak (1469560 st) Søk
Kategorier (2627 st) Søk
Forfattere (167535 st) Søk
Bilder (4592 st)
Født (10495 st)
Døde (3318 st)
Datoer (9517 st)
Land (5315 st)
Idiom (4439 st)
Lengde
Topplistor (6 st)

Ordspråksmusik (20 st)
Statistik

Denna sidan visar ordspråk som liknar "From the get-go, our entire intention was to sign Joe Johnson . As I read some of the reports and listen to some of the commentary about how we kind of duped our fans or tricked our fans or whatever, it's just totally false. We went out of our way to do everything we could to sign Joe Johnson .".

Linkene lenger ned har ikke blitt oversatt till norsk. Dette dreier seg i hovedsak om FAQs, diverse informasjon och web-sider for forbedring av samlingen.

Barnslighet är både skattebefriat och gratis!

Vad är ordtak?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!

Ord värmer mer än all världens elfiltar.

www.livet.se/ordtak

Linkene lenger ned har ikke blitt oversatt till norsk. Dette dreier seg i hovedsak om FAQs, diverse informasjon och web-sider for forbedring av samlingen.

Barnslighet är både skattebefriat och gratis!

Vad är ordtak?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!

Ord värmer mer än all världens elfiltar.

www.livet.se/ordtak